ECG Blog #459 — What did the Paramedics See?
Ken Grauer, MD
DECEMBER 6, 2024
Fri.Dec 06, 2024
130 
Living in a disadvantaged neighborhood linked to higher blood pressure and lower cognition
Medical Xpress - Cardiology
DECEMBER 6, 2024
New research from Wake Forest University School of Medicine suggests that living in a disadvantaged neighborhood is associated with higher blood pressure and lower cognitive scores, even among people who do not have an existing diagnosis of mild cognitive impairment.
Tirzepatide Triumphant Over Semaglutide
CardiacWire
DECEMBER 6, 2024
Topline results from the SURMOUNT-5 trial found Eli Lillys tirzepatide led to far greater weight loss than Novo Nordisks semaglutide, giving Lilly a boost in the race to become Americas go-to GLP-1. Semaglutide and tirzepatide both originally received FDA approval for treating adults with T2D, with those approvals later extending to weight loss management.
U-shaped association seen for alcohol consumption, cardiometabolic disease
Medical Xpress - Cardiology
DECEMBER 6, 2024
There is a U-shaped association between alcohol consumption and coronary heart disease (CHD) and type 2 diabetes (T2D) but no evidence for a causal association, according to a study published online Nov. 24 in Alcohol: Clinical and Experimental Research.
Are there hyperacute T-waves? And how can we know?
Dr. Smith's ECG Blog
DECEMBER 6, 2024
A 50-something man presented with worsening severe exertional chest pain which was just resolving as he had an ECG recorded in triage. Time zero. Are the T-waves in leads I and II hyperacute? Hard to tell. How can we know? By the evolution of the ECG! Watch what happends as the heart recovers from its episode of ischemia. The T-waves deflate, demonstrating that the first one was indeed hyperacute. 2 hours T-waves in lead II are significant smaller In lead I not much difference Troponins returned
Stroke survivors face much higher odds for dementia, research finds
Medical Xpress - Cardiology
DECEMBER 6, 2024
Stroke survivors have an 80% increased risk of dementia compared to people who've never suffered a stroke, a new study finds.
Physiology Friday #247: Underfueling Shifts Metabolism and Compromises Exercise Performance
Physiologically Speaking
DECEMBER 6, 2024
Sign up to get articles personalized to your interests!
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
More Trending
The Silent Heart Risk Hiding in Plain Sight—Decades Before Diagnosis
Dr. Paddy Barrett
DECEMBER 6, 2024
No Link Found Between Allergic Reaction Severity and Allergen Amount
HCPLive
DECEMBER 6, 2024
In this analysis, investigators determined that the eliciting dose of an allergen may be an unpredictable marker for the severity of an allergic reaction.
Reduced-dose anticoagulants not noninferior for recurrent venous thromboembolism
Medical Xpress - Cardiology
DECEMBER 6, 2024
Noninferiority of reduced- versus full-dose anticoagulants cannot be proven in patients with venous thromboembolism who need extended anticoagulation, according to a study to be presented at the annual meeting of the American Society of Hematology, held from Dec. 7 to 10 in San Diego.
Iptacopan Boosts Hemoglobin Levels in Adults with PNH in Phase 3b Trial
HCPLive
DECEMBER 6, 2024
Topline results from APPULSE-PNH show the positive efficacy and safety of twice-daily oral iptacopan in adults with PNH switched from anti-C5 therapies.
ACC CardiaCast: Courtside with the Chair: The Emergence of Pediatric Sports Cardiology, Part 1
American College of Cardiology
DECEMBER 6, 2024
"Courtside with the Chair" is a series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology.
Psilocybin Therapy Eases Clinicians' Depression Post-COVID Frontline Work
HCPLive
DECEMBER 6, 2024
A study found psilocybin therapy brings life-changing relief to depression symptoms triggered by clinicians frontline work during the COVID-19 pandemic.
Holiday Downtime? Here’s How to Upgrade Your Cardiology EHR System
GEMMS
DECEMBER 6, 2024
The holiday season often brings a quieter period for cardiology practices, with fewer patient appointments and a less hectic schedule. This downtime offers the perfect opportunity to focus on internal improvements, such as upgrading your cardiology EHR system. Staying up-to-date with your EHR technology is crucial for providing top-notch patient care, streamlining workflows, and maintaining a competitive edge in the fast-evolving healthcare industry.
Jörn Schattenberg, MD: Preventing MASH Cirrhosis Progression with Pegozafermin
HCPLive
DECEMBER 6, 2024
Schattenberg reviews results from a posthoc analysis of the ENLIVEN study suggesting pegozafermins impact on preventing progression to cirrhosis.
Female-Specific Risk Factors in Cardiovascular Disease: Important or Superfluous?
Circulation: Cardiovascular Quality & Outcomes
DECEMBER 6, 2024
Rheumatology Month in Review: November 2024
HCPLive
DECEMBER 6, 2024
The rheumatology month in review emphasizes new data from ACR 2024 in lupus, gout, and fibromyalgia.
Assessing the Accuracy of Cardiovascular Disease Prediction Using Female-Specific Risk Factors in Women Aged 45 to 69 Years in the UK Biobank Study
Circulation: Cardiovascular Quality & Outcomes
DECEMBER 6, 2024
Biosimilars Month in Review: November 2024
HCPLive
DECEMBER 6, 2024
The biosimilars month in review highlights new equivalency data for denosumab and tocilizumab biosimilars.
RVOT Dysfunction in Repaired TOF: Key Points
American College of Cardiology
DECEMBER 6, 2024
The following are key points to remember from an American Heart Association scientific statement on the long-term management of right ventricular outflow tract (RVOT) dysfunction in repaired tetralogy of Fallot (TOF).
Psychiatry Month in Review: November 2024
HCPLive
DECEMBER 6, 2024
This Month in Review captures November updates in the psychiatry pipeline.
FDA Update: Empty IV Containers Added to Medical Device Shortages List
American College of Cardiology
DECEMBER 6, 2024
The U.S. Food and Drug Administration's (FDA's) Center for Devices and Radiological Health (CDRH) announced the addition of empty intravenous (IV) containers to the agency's Medical Device Shortages List on Dec. 4.
Understanding Pruritus in Primary Biliary Cholangitis
HCPLive
DECEMBER 6, 2024
Andreas Kremer, MD, PhD, MHBA, describes the burden of pruritus in PBC and the toll it can take on patients quality of life.
Feasibility of relaxation along a fictitious field in the 2nd rotating frame (TRAFF2) mapping in the human myocardium at 3 T
Frontiers in Cardiovascular Medicine
DECEMBER 6, 2024
PurposeEvaluate the feasibility of quantification of Relaxation Along a Fictitious Field in the 2nd rotating frame (RAFF2) relaxation times in the human myocardium at 3T.MethodsTRAFF2 mapping was performed using a breath-held ECG-gated acquisition of five images: one without preparation, three preceded by RAFF2 trains of varying duration, and one preceded by a saturation prepulse.
Unmet Needs for Pruritus Management in PBC
HCPLive
DECEMBER 6, 2024
Andreas Kremer, MD, PhD, MHBA, explains shortcomings of traditional PBC therapies for addressing pruritus and what advantages newer agents may offer.
Women's CVD Risk Calculations Barely Budge When Sex-Specific Variables Are Included
Med Page Today
DECEMBER 6, 2024
Emerging Second-Line Therapies in PBC
HCPLive
DECEMBER 6, 2024
Andreas Kremer, MD, PhD, MHBA, reviews emerging therapies in PBC, focusing specifically on seladelpar and its impact on pruritus.
Seladelpar’s Impact on Pruritus
HCPLive
DECEMBER 6, 2024
Andreas Kremer, MD, PhD, MHBA, explains seladelpars impact on pruritus in PBC based on findings from a posthoc analysis of the RESPONSE trial.
The Importance of Patient Education and Shared Decision-Making in CSU
HCPLive
DECEMBER 6, 2024
Panelists discuss how patient education and shared decision-making are crucial in selecting appropriate therapies, as they empower patients to understand their treatment options and actively participate in their care.
The Role of BTK Inhibitors in the Evolving CSU Treatment Landscape
HCPLive
DECEMBER 6, 2024
Panelists discuss how Bruton tyrosine kinase (BTK) inhibitors are reshaping the evolving treatment landscape for chronic spontaneous urticaria (CSU) by providing targeted therapeutic options that address underlying mast cell activation.
Let's personalize your content